Cardinal Health Inc (NYSE:CAH) reported a 38% Y/Y increase in Q2 FY24 adjusted EPS to $1.82, surpassing consensus estimates. Sales rose 12% to $57.45 billion, also beating expectations. The pharmaceutical segment saw a 12% increase, while the Medical segment grew by 3%. Cardinal Health announced the acquisition of Specialty Networks for $1.2 billion, aiming to expand its specialty therapeutic areas. The company raised its FY24 adjusted EPS guidance and forecasts sales growth in its Pharmaceutical and Specialty Solutions and GMPD segments. Despite the positive report, CAH shares dropped 4.30% to $104.49.